A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Clinical trial NCT03922204 · COMPLETED

Trial details

NCT number: NCT03922204
Sponsor: Merus B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Solid Tumor, Adult B-cell Lymphoma, Adult

Start date: 2019-05-08
Primary completion: 2024-11-07
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.